Connect with others who understand.

Sign up Log in
Resources
About MyParkinsonsTeam
Powered By
See answer

Why Are Men More Likely To Develop Parkinson’s?

Medically reviewed by Amit M. Shelat, D.O.
Written by Samantha Eck, Ph.D.
Posted on December 6, 2021

Parkinson’s disease can affect people of any sex or gender. However, male biological sex is a risk factor for Parkinson’s, with the relative risk of developing the condition being about 1.5 times greater in men than women. There are also sex differences in symptom presentation.

The reasons for sex-related disparities in Parkinson’s rates and presentation are currently not well understood. However, research points to both biological and environmental factors that may help explain why men have greater susceptibility to develop Parkinson’s compared to women.

Parkinson’s Risk Factors

The cause of Parkinson’s disease is unknown. Biological sex and environmental factors are both believed to contribute to the sex difference in the risk of developing the disease.

Risk Associated With Biological Sex

There is evidence that estrogen may have protective effects against the development of Parkinson’s disease. Estrogen is a female sex hormone that also acts as a signaling molecule within the brain. A signaling molecule sends information between cells. While all people naturally produce and use estrogen, women tend to have higher levels of estrogen than men. These higher levels of estrogen may offer some protection and contribute to the lower risk of Parkinson’s.

Higher lifetime estrogen exposure has been linked to reduced probability of developing Parkinson’s. Also, observational studies show that while women overall are less likely to develop Parkinson’s compared to men, the incidence of Parkinson’s in post-menopausal women is about the same as in men. This may be due to the reduced estrogen levels in this group.

Parkinson’s disease is characterized by the death of dopamine neurons within an area of the brain called the substantia nigra. These neurons are crucial for motor control, and their death underlies the loss of muscle control in people with Parkinson’s. Estrogens are well known to enhance the brain’s ability to produce dopamine and use it as a signaling molecule. This enhancement of dopamine signaling may counteract the development of Parkinson’s symptoms.

Estrogen may also help protect against Parkinson’s by preventing dopamine neuron death.

In rodent models of Parkinson’s, researchers have administered a drug that kills dopamine neurons in the substantia nigra to mimic Parkinson’s symptoms. Administration of estrogen protects dopamine neurons from this drug-induced cell death. The protective effect of estrogens on dopamine neurons within the substantia nigra may also contribute to the reduced risk of Parkinson’s in women.

Risk Associated With Environmental Factors

Lifetime exposure to heavy metals or certain pesticides has been linked to increased risk of developing Parkinson’s. Some types of jobs — like farming, woodworking, or metalworking — can lead to more exposure to these materials. People who work these jobs, therefore, may be at a higher risk for Parkinson’s. Some suggest that the higher prevalence of men working in these occupations may contribute to the greater risk of Parkinson’s disease in men compared to women.

Head trauma has also been linked to increased risk for Parkinson’s disease. A higher incidence of head injuries in men compared to women may also contribute to increased Parkinson’s risk.

Biological Sex Differences in Symptom Presentation

There is a large amount of variability in how people develop Parkinson’s. Men and women on average tend to exhibit different symptoms of Parkinson’s, with different levels of severity. Some studies report that women are more likely than men to exhibit the following nonmotor symptoms:

  • Fatigue
  • Restless legs
  • Depression
  • Weight change
  • Constipation
  • Loss of taste or smell
  • Pain
  • Excessive sweating

Men with Parkinson’s disease are more likely than women to present with impairments in cognition. These impairments could include deficits in attention and working memory, as well as changes in impulse control.

Talk With Others Who Understand

MyParkinsonsTeam is the social network for people with Parkinson’s and their loved ones. On MyParkinsonsTeam, more than 80,000 members come together to ask questions, give advice, and share their stories with others who understand life with Parkinson’s.

Are you living with Parkinson’s? Share your experience in the comments below, or start a conversation by posting on your Activities page.

Posted on December 6, 2021

A MyParkinsonsTeam Subscriber

Love these articles
Feeling less alone

January 9
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy

So Why Isn’t Estrogen Part Of My Parkinson’s Treatment?

January 8, 2024 by A MyParkinsonsTeam Member 3 answers

I Have A Problem With Shortness-of-breath And Fatigue Right At Pill Dosage Time. None Else Male Or Female Seems To Have This.

January 9, 2024 by A MyParkinsonsTeam Member 3 answers
Amit M. Shelat, D.O. is a fellow of the American Academy of Neurology and the American College of Physicians. Review provided by VeriMed Healthcare Network. Learn more about him here.
Samantha Eck, Ph.D. has been conducting behavioral neuroscience research since 2014 and earned her Ph.D. in psychology from Temple University. Learn more about her here.

Recent Articles

Treatments for Parkinson’s disease aim to manage symptoms and improve quality of life. However, i...

Potential Side Effects of Parkinson’s Disease Treatment

Treatments for Parkinson’s disease aim to manage symptoms and improve quality of life. However, i...
This fall and winter, the Centers for Disease Control and Prevention (CDC) expects the number of ...

3 Layers of COVID-19 Protection: New Vaccines, Prevention Drug, and Tests

This fall and winter, the Centers for Disease Control and Prevention (CDC) expects the number of ...
Parkinsonism is a syndrome (collection of symptoms and signs) characterized by bradykinesia (slow...

Parkinson’s Disease and Parkinsonism – An Overview

Parkinsonism is a syndrome (collection of symptoms and signs) characterized by bradykinesia (slow...
4 Ways To Reduce the Cost of Medication The price of medication affects the quality of life f...

4 Ways To Reduce the Cost of Medication (VIDEO)

4 Ways To Reduce the Cost of Medication The price of medication affects the quality of life f...
The journey to a Parkinson's disease diagnosis can be lengthy and uncertain, especially when a pe...

Parkinson’s Disease – The Path to Diagnosis

The journey to a Parkinson's disease diagnosis can be lengthy and uncertain, especially when a pe...
Parkinsonism is a syndrome, or collection of symptoms, characterized by motor issues — bradykines...

Types of Parkinsonism

Parkinsonism is a syndrome, or collection of symptoms, characterized by motor issues — bradykines...

Thank you for subscribing!

Become a member to get even more: